Emergent BioSolutions EBS
$ 9.39
5.86%
Annual report 2023
added 03-08-2024
Country |
USA |
IPO year |
2006 |
Industry |
Drug manufacturers |
Stock Exchange |
NYSESPB |
CEO |
Mr. Robert Kramer |
Employees in the company |
1 834 |
Shares |
51.2 M |
Market Cap[1] |
$ 481 M |
EBITDA (LTM) |
$ -238 M |
P/E (LTM) |
-0.29 |
P/S (LTM) |
0.09 |
EPS (LTM) |
-7.51 |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.